What it actually takes to launch a compliant telehealth brand in 2026

A telehealth brand looks simple from the outside. A patient lands on a page, answers some questions, pays, and a prescription shows up at the door a few days later. Behind that page sits a medical practice, a licensed clinician for every state you serve, a pharmacy relationship, a payment stack that card networks will tolerate, and a data environment that has to hold up to a HIPAA review. Most launches stall not on the storefront but on the parts patients never see.

This guide walks through those parts in the order they usually need to happen. It is not legal advice. Rules vary by state and change often, so treat every section as a list of questions to take to your own healthcare counsel.

Start with the legal structure, not the website

The first question is who is practicing medicine. In many states, a company that is not owned by licensed physicians cannot employ physicians or control clinical decisions. This is the corporate practice of medicine doctrine, and it shapes everything downstream.

The common answer is an MSO-PC structure. A management services organization (the MSO) owns the brand, the technology, the marketing, and the business operations. A professional corporation (the PC), owned by one or more licensed physicians, employs or contracts the clinicians and makes every clinical decision. A management services agreement connects the two. We cover this in depth in a separate plain-language explainer on MSO-PC and corporate practice of medicine, but the short version is this: decide the structure before you sign a lease on anything, including software.

Questions to settle early:

Which entity contracts with patients, and which entity bills them?
Who owns the professional corporation, and in which states is that owner licensed?
How will management fees be set, and has counsel confirmed they fit the fee-splitting rules in the states you plan to serve?
Who owns the patient record, and who acts as the covered entity under HIPAA?

Decide your clinical model

You need clinicians licensed in each state where your patients are located at the time of the visit. That is the rule that trips up most new brands: licensure follows the patient, not the clinician or the company.

You have two broad options.

Bring your own clinicians. You recruit, credential, and license physicians and nurse practitioners, and you manage their schedules, quality review, and state-by-state licensure. This gives you control and a clinical voice that matches your brand. It also makes you responsible for coverage gaps.
Use a provider network. A partner supplies clinicians who are already licensed and credentialed, usually working under a medical director. You trade some control for speed and coverage.

Either way, write down your clinical protocols before you launch. For each program, define eligibility criteria, contraindications, required labs, when a synchronous visit is required instead of an asynchronous review, follow-up cadence, and escalation paths. Some states require a synchronous audio or video encounter for certain prescriptions or for establishing a relationship. Your intake and visit flow must be able to switch modes by state and by program.

Prescribing rules deserve their own review

Controlled substances carry federal rules on top of state rules, and the federal rules for telehealth prescribing of controlled substances have been in flux for several years. If any program touches a controlled substance, get specific counsel on the current federal position and each state's requirements before you design the flow.

Pick a pharmacy path you can explain

Patients receive medication through one of two channels: a retail or mail-order pharmacy filling a standard prescription, or a compounding pharmacy preparing a personalized formulation.

If you plan to offer compounded medications, understand the distinction between the two federal categories:

503A pharmacies compound based on patient-specific prescriptions. They are primarily overseen by state boards of pharmacy.
503B outsourcing facilities are registered with the FDA, follow current good manufacturing practice requirements, and can produce larger batches, often for office use.

Compounded drugs have not gone through FDA approval. Your marketing must not imply otherwise, and claims about compounded products draw scrutiny from regulators and advertising platforms alike. Ask any pharmacy partner for its licenses in each state it ships to, its inspection history, its sourcing of active ingredients, and how it handles adverse event reporting. Our pharmacy fulfillment overview describes how we approach a 503A personalized compounding lane.

Build payments that will survive a review

Telehealth sits in a category many card processors treat as higher risk, especially when prescriptions or compounded medications are involved. Plan for that.

Know who your merchant of record is. It should line up with the entity that contracts with the patient.
Separate the clinical fee from the medication cost where your structure and state rules call for it, and make the split visible to the patient.
Write clear refund and cancellation terms before launch. Subscription billing for medication programs draws chargebacks when terms are vague.
Avoid lock-in. If your platform forces its own processor and adds an undisclosed margin on top, you lose the ability to shop rates or move later. Look for a stack that lets you bring your own processor.

Treat data protection as an operating discipline

HIPAA is not a certificate you buy. There is no official certification for HIPAA. It is a set of administrative, physical, and technical safeguards you have to run every day, plus business associate agreements with every vendor that touches protected health information.

At minimum, expect to have:

A signed BAA with every vendor that stores, processes, or transmits PHI, including your hosting provider, email and SMS vendors, analytics tools, and any AI service.
A written risk assessment, refreshed on a schedule.
Encryption in transit and at rest, multi-factor authentication, role-based access control, and audit logging of who viewed what.
A process for patient access requests and breach response.

Watch marketing pixels carefully. Tracking tools on pages where a patient enters health information have drawn regulatory attention in recent years. Keep analytics consent-gated and keep health data out of ad platforms. Our security page and compliance page describe the controls we run.

Write marketing that a regulator could read

Your advertising is held to the same standards as any healthcare claim, and advertising platforms add their own rules for prescription products. A few practical guardrails:

Do not promise outcomes. Describe what the program includes, not what a patient will achieve.
Do not imply that a compounded medication has been approved by the FDA.
Show the full price, including medication and any recurring charges, before checkout.
Make clear that a licensed clinician decides whether treatment is appropriate.

A realistic launch sequence

Here is the order that tends to work:

Engage healthcare counsel and settle the MSO-PC structure and the states you will serve first.
Define programs and write clinical protocols with your medical director.
Secure clinician coverage for each launch state.
Contract with a pharmacy and confirm its licensure in every launch state.
Set up the payment stack and confirm your merchant category and terms.
Configure intake, the clinical workflow, and e-prescribing, then test every state and program path end to end.
Sign BAAs, complete the risk assessment, and lock down access controls.
Review all patient-facing copy with counsel.
Launch in a small set of states, watch the operational dashboards closely, and expand once the workflow is stable.

Steps 1 through 4 often take longer than the technology. Plan your calendar around them.

Where a platform fits

You can assemble all of this yourself, and some operators should. Others prefer a partner that runs the clinic behind the brand. Vayra runs its own direct-to-consumer practice on the same stack it offers to operators, with Vayra Health & Wellness, Inc. as the MSO and Vayra Medical, P.C. as the separate professional corporation that provides clinical services. That means the structure, the clinical workflow, the pharmacy lane, and the dashboards are already in daily use. You can use our clinicians or bring your own, and you keep full ownership of your data. See launching a brand with Vayra for how that works in practice.

If you want to walk through your launch plan with someone who runs one, Book a demo.